Camelia Vidita GURBAN

Dr. Camelia Vidita GURBAN


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2022 in Antibiotics
Verified
Journal Article
Open access
PDF file
IViulia Vidican
iulia Vidican
CCCosmin Ioan Citu
Cosmin Ioan Citu
Felix BratosinFelix Bratosin
Felix Bratosin
DMDaniel Malita
Daniel Malita
IRIoan Romosan
Ioan Romosan
Iosif MarincuIosif Marincu
Iosif Marincu
The multiplex PCR is a powerful and efficient tool that was widely used during the COVID-19 pandemic to diagnose SARS-CoV-2 infections and that has applications for bacterial identification, as well as determining bacterial resistance to antibiotics. Therefore, this study aimed to determine the usability of multiplex PCR, especially in patients self-medicated with antibiotics, where bacterial cultures often give false-negative results. A cross-sectional study was developed in two COVID-19 units, where 489 eligible patients were included as antibiotic takers and non-antibiotic takers. Antibiotic takers used mostly over-the-counter medication; they suffered significantly more chronic respiratory conditions and were self-medicated most often with cephalosporins (41.4%), macrolide (23.2%), and penicillin (19.7%). The disease severity in these patients was significantly higher than in non-antibiotic takers, and bacterial superinfections were the most common finding in the same group (63.6%). Antibiotic takers had longer hospital and ICU admissions, although the mortality rate was not significantly higher than in non-antibiotic takers. The most common bacteria involved in secondary infections were Staphylococcus aureus (22.2%), Pseudomonas aeruginosa (27.8%), and Klebsiellaspp (25.0%). Patients self-medicating with antibiotics had significantly higher rates of multidrug resistance. The multiplex PCR test was more accurate in identifying multidrug resistance and resulted in a quicker initiation of therapeutic antibiotics compared with instances where a bacterial culture was initially performed, with an average of 26.8 h vs. 40.4 h, respectively. The hospital stay was also significantly shorter by an average of 2.5 days when PCR was used as an initial assessment tool for secondary bacterial infections. When adjusted for age, COVID-19 severity, and pulmonary disease, over-the-counter use of antibiotics represented a significant independent risk factor for a prolonged hospitalization (AOR = 1.21). Similar findings were observed for smoking status (AOR = 1.44), bacterial superinfection (AOR = 1.52), performing only a conventional bacterial culture (AOR = 1.17), and a duration of more than 48 h for bacterial sampling from the time of hospital admission (AOR = 1.36). Multiplex PCR may be a very effective method for diagnosing secondary bacterial infections in COVID-19 individuals self-medicating with antibiotics. Utilizing this strategy as an initial screen in COVID-19 patients who exhibit signs of sepsis and clinical deterioration will result in a faster recovery time and a shorter period of hospitalization.

MTMirela Turaiche
Mirela Turaiche
MGMirela Grigoras
Mirela Grigoras
Felix BratosinFelix Bratosin
Felix Bratosin
IViulia Vidican
iulia Vidican
Adrian BotaAdrian Bota
Adrian Bota
Iosif MarincuIosif Marincu
Iosif Marincu
Measles causes in vaccinated children, with some exceptions, a mild disease, while the unvaccinated can suffer complications that result in serious consequences and even death. Although the introduction of the measles vaccine has reduced the number of cases and the viral spread, the current downward vaccination trend has resulted in the resurgence of the disease. Currently, Romania has a measles vaccination coverage below the 95% safety threshold. Thus, an outbreak started in 2016 and still ongoing in Romania, many cases being identified in the Western region in the pediatric population. Our objective was to conduct a thorough examination of clinical characteristics, evolution, and risk factors in vaccinated and unvaccinated children in this region. To reach our objectives we used a retrospective cohort analysis. The authors reviewed clinical and laboratory data from patients hospitalized at “Victor Babes” Hospital for Infectious Diseases and Pulmonology in Timisoara. We found a total of 136 qualifying cases of measles among the children admitted to this facility. The two comparison groups consisted of 104 children under 10 years and 32 patients between 10 and 18 years. An important characteristic of both study groups was the high prevalence of patients from the Roma ethnicity, which, although represents a minority in Romania, the prevalence was over 40% in the current study. The infection source was in 40.4% of children under 10 years inside the family, while 71.9% of infections in the group of adolescents were isolated (p-value = 0.047). The multivariate risk factor analysis identified as independent risk factors for the development of pneumonia the older age of patients (OR = 1.62), poor nutritional status (OR = 1.25), Roma ethnicity (OR = 2.44), presence of anemia (OR = 1.58), and procalcitonin (OR = 3.09). It is essential to handle these risk factors in a patient with measles, especially in conjunction with an unknown vaccination status. To achieve a vaccination rate greater than 95 percent for Romanian children, measles vaccination awareness must be promoted, moreover in the Roma population. More comprehensive preventative methods must be developed promptly with the objective of eradicating measles in Romania via a vigorous vaccination campaign.

10 February 2022 in Journal of Personalized Medicine
Verified
Journal Article
Open access
PDF file
Iosif MarincuIosif Marincu
Iosif Marincu
CCCosmin Ioan Citu
Cosmin Ioan Citu
Felix BratosinFelix Bratosin
Felix Bratosin
IViulia Vidican
iulia Vidican
MTMadalina Timircan
Madalina Timircan
MGMirela Grigoras
Mirela Grigoras
Although laboratory data show that antibody responses to COVID-19 immunization give superior neutralization of certain circulating variations to spontaneous infection, few real-world epidemiological studies demonstrate the advantage of vaccination for previously infected individuals. This paper summarizes the outcomes of a case–control study conducted in Romania between March 2020 and October 2021 on patients previously infected with SARS-CoV-2. A case–control study was implemented after identification of 62 breakthrough cases. These cases were matched by age and gender to a 1:1 ratio with a control group of unvaccinated patients with SARS-CoV-2 reinfection status. There were no significant differences in the severity of cases and mortality between the study groups. However, unvaccinated patients had a shorter protection from natural immunity than patients with full vaccination status (58 days versus 89 days). The unvaccinated cases with SARS-CoV-2 reinfection were also statistically more likely to have a longer hospital admission duration (12.4 days versus 9.8 days), and required more non-invasive oxygen supplementation during their stay than breakthrough cases (37.1% versus 19.4%). Individuals with prior SARS-CoV-2 infection who were not vaccinated are not at a higher risk of severe COVID-19 infection or mortality compared to those who were completely vaccinated with the mRNA vaccine Comirnaty® Pfizer/BioNTech BNT162b2 and acquired a breakthrough infection within 2–3 months of the previous infection with a Beta or Delta SARS-CoV-2 variant. Although our findings are consistent with natural immunity offering similar short-term protection to a second dose of mRNA vaccine, all eligible individuals should be provided with immunization to lower their risk of infection, even if they have already been infected with SARS-CoV-2.

7 September 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
MTMirela Turaiche
Mirela Turaiche
BFBogdan Feciche
Bogdan Feciche
AGADRIAN GLUHOVSCHI
ADRIAN GLUHOVSCHI
Felix BratosinFelix Bratosin
Felix Bratosin
IViulia Vidican
iulia Vidican
Iosif MarincuIosif Marincu
Iosif Marincu
Measles is a highly infectious and sometimes deadly illness that is preventable with vaccination. The present research aims to analyze the most recent measles epidemic from Romania that occurred in a population with a falling desire to receive immunizations, by detailing the clinical picture and biological profile of hospitalized patients. A secondary goal of the present research is to identify characteristics that increase the likelihood of a longer hospitalization and the development of measles-related pneumonia. A retrospective cohort study was conducted to follow the course and effects of measles virus infection in adult hospitalized patients who were divided into two groups based on whether they had been in the hospital for more than 6 days or fewer than 6 days. A total of 114 adult patients with measles were eligible to participate in the trial if they had a positive measles-specific IgM antibody test resulting from the study. The average age in the short hospital stay group was 28.1 years, while the average age in the long hospital stay group was 31.9 years. There was a statistically significant difference in the number of Roma persons in the research groups, with 17.4 percent of them having a lengthy hospital stay compared to 5.9 percent in the group with a short hospital stay, according to the findings. It was observed that many patients had a long hospitalization associated with chronic lung disease (OR = 1.07), liver damage (OR = 1.66), Roma ethnicity (OR = 1.79), a long duration elapsed from the last MMR dose (OR = 2.02), elevated c-reactive protein (OR = 2.17), the presence of bilateral pulmonary condensations on X-ray (OR = 3.13), and elevated procalcitonin (OR = 3.49). The same significant independent risk factors were also associated with the development of pneumonia. It is of imperative need to address these risk factors in a patient with measles, moreover in association with an unknown status of vaccination. Vaccination awareness against measles must be pushed in Romania to determine a higher than 95% coverage. Significant efforts are still needed to ensure improved protection against measles epidemics within a specific region or population and, more importantly, in patients with significant risk factors for complications, as described in this study.

30 April 2024 in Diagnostics
Verified
Journal Article
Open access
PDF file
AFAlexandra Corina Faur
Alexandra Corina Faur
CGCamelia Vidita GURBAN
Camelia Vidita GURBAN
EDEcaterina Daescu
Ecaterina Daescu
RTRăzvan Vlad Tîrziu
Răzvan Vlad Tîrziu
DLDaniela Cornelia Lazar
Daniela Cornelia Lazar
LGLaura Andreea Ghenciu
Laura Andreea Ghenciu
Breast cancer stands as the primary cause of cancer-related mortality among women worldwide, often presenting with distant metastases upon diagnosis. Ovarian metastases originating from breast cancer represent a range of 3–30% of all ovarian neoplasms. Case Report: Herein, we present the histopathological, histochemical, and immunohistochemical findings of a rare case involving mucin-producing lobular breast carcinoma metastasizing to an ovarian fibroma in an 82-year-old female previously diagnosed with lobular breast carcinoma. Histopathological examination of the excised tissues revealed a biphasic neoplasm characterized by tumor cells expressing AE-1/AE-3 cytokeratin, mammaglobin, GCDFP-15, inhibin, and calretinin. Positive mucin staining was observed using histochemical techniques, and reticulin fibers were demonstrated using the Gordon–Sweets technique. A final diagnosis of mucin-producing lobular breast carcinoma metastatic to a benign ovarian fibroma was rendered. Conclusion: The occurrence of metastatic breast carcinoma overlaid on an ovarian tumor represents a rare and diagnostically challenging scenario.

2 August 2023 in Clinical and Experimental Obstetrics & Gynecology
Verified
Journal Article
Open access
PDF file
AFAlexandra Corina Faur
Alexandra Corina Faur
LGLaura Andreea Ghenciu
Laura Andreea Ghenciu
CGCamelia Vidita GURBAN
Camelia Vidita GURBAN
DLDaniela Cornelia Lazăr
Daniela Cornelia Lazăr
Background: Conventional cervicovaginal Papanicolaou (Pap) stained smears are a common investigation in gynaecological practice for detecting cancerous and precancerous cervicovaginal lesions, as well as infections and inflammatory processes. Although Candidiasis is the most common fungal infection detected on Pap smears, cytopathologists sometimes also have to deal with the challenge of fungal contaminants. The aim of this study is to present and discuss the findings of two rare fungal organisms in the context of previous literature reports. Methods: Over a period of one year, 4496 smears were submitted to the cytopathology laboratory for analysis. These were sampled from women aged 16–72 years. Slides were processed using the conventional Papanicolaou stain (Pap stain) method. The current available literature was reviewed using relevant key words. Results: Of the 4496 smears examined, the most frequently detected fungal species was Candida species spp. (523 cases), followed by Gardnerella Vaginalis (450 cases) and Trichomonas Vaginalis (50 cases). Also identified were 20 cases with Actinomyces spp. and 18 cases with unusual contaminants belonging to Penicillium and Alternaria spp. A literature search found that five previous articles reported cervical cytology cases with Penicillium and Alternaria spp. Conclusions: Papanicolaou smears are useful for the detection of vaginal microorganisms. Usual pathogenic flora need to be distinguished from contaminants such as Penicillium and Alternaria spp., as observed in this and previous studies.